Sorafenib Monotherapy vs. TACE-sorafenib Sequential Therapy for HCC With Metastasis

Clinical trial NCT03518502 · UNKNOWN

Trial details

NCT number: NCT03518502
Sponsor: Korea University
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Metastasis

Start date: 2012-03-01
Primary completion: 2020-02-28
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.